Comments on: Springer buys open access publisher BioMed Central http://blog.openwetware.org/community/2008/10/07/springer-buys-open-access-publisher-biomed-central/ Share your science Wed, 12 May 2010 23:30:55 +0000 hourly 1 http://wordpress.org/?v=3.1.4 By: rpg http://blog.openwetware.org/community/2008/10/07/springer-buys-open-access-publisher-biomed-central/#comment-121 rpg Tue, 07 Oct 2008 23:08:33 +0000 http://blog.openwetware.org/community/?p=182#comment-121 Hah hah. I don't know if it's a genuine attempt or cynical marketing. It doesn't actually matter (unless of course they then 'close' BMC). Publishers have to realize that OA is becoming more and more desired in the scientific community. Springer have a lot of catching up to do. But it's a good thing, even if the reasons are cynical: it improves the perception and acceptability of OA elsewhere. Hah hah. I don’t know if it’s a genuine attempt or cynical marketing. It doesn’t actually matter (unless of course they then ‘close’ BMC).

Publishers have to realize that OA is becoming more and more desired in the scientific community. Springer have a lot of catching up to do.

But it’s a good thing, even if the reasons are cynical: it improves the perception and acceptability of OA elsewhere.

]]> By: wim van der stelt http://blog.openwetware.org/community/2008/10/07/springer-buys-open-access-publisher-biomed-central/#comment-120 wim van der stelt Tue, 07 Oct 2008 15:51:30 +0000 http://blog.openwetware.org/community/?p=182#comment-120 I quote Derk Haank, Springer's CEO from our press release regarding the BioMed Central acquisition: “This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade. We have gained considerable positive experience since starting Springer Open Choice in 2004, and BioMed Central’s activities are complementary to what we are doing. Additionally, this acquisition strengthens Springer’s position in the life sciences and biomedicine, and will allow us to offer societies a greater range of publishing options.” This statement clearly shows Springer's commitment to BioMed Central's publishing model. Here's a link to the complete press release: http://www.springer-sbm.com/index.php?id=291&backPID=132&L=0&tx_tnc_news=4970&cHash=b5a2aa41d8 I quote Derk Haank, Springer’s CEO from our press release regarding the BioMed Central acquisition:

“This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade. We have gained considerable positive experience since starting Springer Open Choice in 2004, and BioMed Central’s activities are complementary to what we are doing. Additionally, this acquisition strengthens Springer’s position in the life sciences and biomedicine, and will allow us to offer societies a greater range of publishing options.”

This statement clearly shows Springer’s commitment to BioMed Central’s publishing model.

Here’s a link to the complete press release:

http://www.springer-sbm.com/index.php?id=291&backPID=132&L=0&tx_tnc_news=4970&cHash=b5a2aa41d8

]]>